ArticleClinical genitourinary cancer2020

A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer.

Deaglan J McHugh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.